Search
for
Sort by
Research 181–210 of 564
- Valproate: It's effects on hair
- A case of androgenetic alopecia treated with valproic acid
- Psychiatric disorders in women with polycystic ovary syndrome
- Culture of amelanotic melanocytes derived from human fetal hair follicles
- Hair loss due to aripipirazole use: a case report
- CURRENT PROSPECTIVE IN THE MANAGEMENT OF DEPRESSION USING OFF LABELLED DRUGS AND ADVANCED DRUGS
- Editorial
- Agomelatine may alleviate valproate induced hair loss
- P.6.028 Transnosography of impulsiveness:A comparison among different psychiatric disorders
- Agitation as a Paradoxical Effect of Divalproex Sodium: A Case Report
- Alopecia and Mood Stabilizer Therapy
- GSK-3 Inhibitors: Recent Developments and Therapeutic Potential
- Visualising the Novosel Formula: Comments on Dahl and Berg’s A formula for the mean electrical axis of the heart
- Finasteride use and suicide attempts through self-poisoning: A case–control study
- P-50 WE KNOW YOU ARE THERE: MISSING MASS
- Table of Contents
- Morphologic comparison of cultured human epidermis melanocytes,amelanotic melanocytes from hair follicles and mouse melanoma cells observed by atomic force microscope
- Finasteride Blocks the Reduction in Ictal Activity Produced by Exogenous Estrous Cyclicity
- Adverse Cutaneous Reactions to Antipsychotics
- Adverse Cutaneous Reactions to Mood Stabilizers
- Marie Antoinette Syndrome
- Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma
- IMMUNOPATHOLOGY OF THE HUMAN HAIR FOLLICLE
- Risk of valproic acid-related alopecia: A systematic review and meta-analysis
- Optimization of the method for the culture of melanocyte precursors from hair follicles and their activation by 1,25-dihydroxyvitamin D3
- Congenital Combined Melanocytic Nevus of the Scalp With Associated Alopecia Areata
- Valproate-Associated Transaminitis and Rhabdomyolysis
- Topical Valproate Solution for Hair Growth
- Eosinophilia associated with clozapine – A case report
- Drug Repurposing Patent Applications July–September 2025